KFDA approves first embryonic stem cell study
The Korea Food and Drug Administration said it has approved CHA Bio & Diostech’s request to conduct a clinical study using embryonic stem cell in treating macular degeneration which can lead to ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
